John Montana - Profile and Investment Details

Investor Profile

John Montana is a Venture Capital, Private Equity Firm, Investment Partner based in Saffron Walden, England, United Kingdom with a diverse investment portfolio that includes companies such as Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems, Borean Pharma, Roche Glycart, NovoGI, Oxyrane UK, OMEICOS Therapeutics, Inflazome, Amakem, Pulmologix, Ardana Bioscience, CoviCept Therapeutics, Rigontec, FlowMedica, Oxular, NeRRe Therapeutics, Hookipa Pharma, NorthSea Therapeutics, SANIFIT, PneumRx, Gotham Therapeutics, Catalym, Insmed, Mitralign, Prilenia, KaNDy Therapeutics, Ario Pharma, Cardoz, CircuLite, BioVex, Cytheris, Bluebird Bio, Pieris AG, UniQure, CellNovo, Akarna Therapeutics, Escalier Biosciences, Azafaros, Enterprise Therapeutics, Bioceros, Replimune Group, Exosome Diagnostics, Acorda Therapeutics, Dyne Therapeutics, gIcare Pharma, Amphista Therapeutics, Milestone Pharmaceuticals, Dezima Pharma, Fovea Pharmaceuticals, Inversago Pharma, Gyroscope Therapeutics, New Amsterdam Pharma, Autonomic Technologies, Xention, Achilles Therapeutics, arGEN-X, Curetis, ACADIA Pharmaceuticals, Allecra Therapeutics, PanGenetics, Promedior, Transave, Argos Therapeutics, enGene, Prexton Therapeutics. Over time, John Montana has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether John Montana is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Medical Testing, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Genomics, Health Diagnostics, Medical, Real Estate, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with John Montana, as their portfolio suggests a familiarity and interest in this area.

Understanding John Montana’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.